India's Pharmaceutical Exports

Country Profile

Belize

Belize is a developing market for Indian pharmaceuticals — $1.23M in FY 2025–26, with 2.8× growth over the past decade. Medicines accounts for 79% of shipments, with vaccines contributing $113K. The compound annual growth rate since FY2015 stands at 9.7%.

🇧🇿 $1.23M · 2.8× growth since FY2015 · 9.7% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$1.23M
Exports FY2025–26 DGCIS
2.8×
Growth FY2015→2026
9.7%
CAGR FY2015→2026
79%
Medicines Share
4
Product Categories Supplied
Belize is a developing market for Indian pharmaceuticals — $1.23M in FY 2025–26, with 2.8× growth over the past decade. Medicines accounts for 79% of shipments, with vaccines contributing $113K. The compound annual growth rate since FY2015 stands at 9.7%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $973K (79.0%) Surgical & Hospital Supplies $137K (11.1%) Vaccines $113K (9.2%) Traditional & Herbal $8K (0.6%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Belize in the RBI overseas direct investment dataset (2011–2026).